AbbVie Inc. Capital Expenditures 2011-2026 | ABBV
Beta
What is capital expenditures?
Capital expenditures (CapEx) can be defined as money spent on acquiring, maintaining, or upgrading physical assets such as property, buildings, and equipment.
What is AbbVie Inc.'s current capital expenditures?
AbbVie Inc. (ABBV) annual capital expenditures for 2025 was $1.21B, a 24.64% increase from 2024. AbbVie Inc. capital expenditures for the quarter ending March 31, 2026 was $265.0M.
What was AbbVie Inc.'s capital expenditures in 2024?
AbbVie Inc. annual capital expenditures for 2024 was $974.0M, a 25.35% increase from 2023.
What was AbbVie Inc.'s capital expenditures in 2023?
AbbVie Inc. annual capital expenditures for 2023 was $777.0M, a 11.80% increase from 2022.
What is AbbVie Inc.'s 5-year capital expenditures CAGR?
AbbVie Inc. capital expenditures grew at a compound annual growth rate (CAGR) of 8.75% from FY2020 to FY2025, going from $798.0M to $1.21B over 5 years.
Capital Expenditures History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+8.8%
FY2020
$798.0M
→
FY2025
$1.21B
111213141516171819202122232425
5 years selected
Capital Expenditures History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.21B | +24.6% | 10-K |
| FY2024 | $974.0M | +25.4% | 10-K |
| FY2023 | $777.0M | +11.8% | 10-K |
| FY2022 | $695.0M | -11.7% | 10-K |
| FY2021 | $787.0M | -1.4% | 10-K |
| FY2020 | $798.0M | +44.6% | 10-K |
| FY2019 | $552.0M | -13.5% | 10-K |
| FY2018 | $638.0M | +20.6% | 10-K |
| FY2017 | $529.0M | +10.4% | 10-K |
| FY2016 | $479.0M | -10.0% | 10-K |
| FY2015 | $532.0M | -13.1% | 10-K |
| FY2014 | $612.0M | +24.6% | 10-K |
| FY2013 | $491.0M | +47.4% | 10-K |
| FY2012 | $333.0M | -6.5% | 10-K |
| FY2011 | $356.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →